Mortality PredictionDiagnostics and screeningDiagnostic test
What this study is
The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM.
What's being tested
- blood sample to check CXCL9 pre stem cell transplant and cell therapy
Intervention · DIAGNOSTIC TEST
Pre SCTCT as per SOC physical function assessment will be performed in a form of IADl, hand grip, and or walk test like TUG. Specimen Collection Studies: LDH , albumin, ferritin, CRP, platelet and creatinine will be collected as per standard of care pre SCTCT. The non-SOC procedure will be drawing CXL9
Study details
- Official title
- BIO-FUNCTION for NRM Prediction in SCTCT: Assessing Biological and Functional Reserve to Predict Non-Relapse Mortality in Stem Cell Transplant and Cell Therapy
- Sponsor
- Henry Ford Health System
- Conditions
- Mortality Prediction
- Enrolling
- 124 people
- Starts
- 2026-10-01
- Est. completion
- 2031-12-30
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients >18 year old
- Patients planned for SCTCT
You can't join if
- Pregnancy
- Prisoners
- Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 open- Recruiting
Study team
Sponsor
Henry Ford Health System
Study ID 19170
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.